Literature DB >> 22866131

A novel mutation in BRCA1 linked to breast and ovarian cancer and a genotype-phenotype correlation.

Josefa Salgado1, José M Aramendía, Cristina Gutiérrez, Carmen Gil, Maitane Robles, Jesús García-Foncillas.   

Abstract

We report a novel BRCA1 germline 4156delAA mutation detected in a 41-year-old woman with breast and ovarian cancer. Genomic DNA was obtained from peripheral blood. Standard polymerase chain reactions and direct sequencing were performed. This mutation originates a premature stop at codon 1354 of BRCA1 protein and has not been documented in any published report to the best of our knowledge. The mutation was not observed in any other family studied. Since this novel mutation was associated with both breast and ovarian cancer, the genotype-phenotype correlation was investigated in a patient base of 30 families.

Entities:  

Year:  2011        PMID: 22866131      PMCID: PMC3408106          DOI: 10.3892/ol.2011.328

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  14 in total

1.  "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.

Authors:  David S P Tan; Christian Rothermundt; Karen Thomas; Elizabeth Bancroft; Rosalind Eeles; Susan Shanley; Audrey Ardern-Jones; Andrew Norman; Stanley B Kaye; Martin E Gore
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

2.  Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.

Authors:  S A Gayther; J Mangion; P Russell; S Seal; R Barfoot; B A Ponder; M R Stratton; D Easton
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

3.  Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula.

Authors:  A Vega; M Torres; J I Martínez; C Ruiz-Ponte; F Barros; A Carracedo
Journal:  Ann Hum Genet       Date:  2002-01       Impact factor: 1.670

4.  Variation in BRCA1 cancer risks by mutation position.

Authors:  Deborah Thompson; Douglas Easton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-04       Impact factor: 4.254

5.  Comparative disease pattern of a patient with a novel BRCA2 truncation and knockout models for BRCA2.

Authors:  Josefa Salgado; Cristina Gutiérrez; Carmen Gil; Maitane Robles; Jesús García-Foncillas
Journal:  Breast Cancer Res Treat       Date:  2010-02-12       Impact factor: 4.872

6.  Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

Authors:  D Thompson; D Easton
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

7.  Microcephalin regulates BRCA2 and Rad51-associated DNA double-strand break repair.

Authors:  Xianglin Wu; Gourish Mondal; Xianshu Wang; Jianmin Wu; Lin Yang; Vernon S Pankratz; Matthew Rowley; Fergus J Couch
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

8.  Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.

Authors:  Orland Díez; Ana Osorio; Mercedes Durán; José Ignacio Martinez-Ferrandis; Miguel de la Hoya; Raquel Salazar; Ana Vega; Berta Campos; Raquel Rodríguez-López; Eladio Velasco; Javier Chaves; Eduardo Díaz-Rubio; Juan Jesús Cruz; María Torres; Eva Esteban; Andrés Cervantes; Carmen Alonso; Juan Manuel San Román; Rogelio González-Sarmiento; Cristina Miner; Angel Carracedo; María Eugenia Armengod; Trinidad Caldés; Javier Benítez; Montserrat Baiget
Journal:  Hum Mutat       Date:  2003-10       Impact factor: 4.878

9.  Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo.

Authors:  Pierfrancesco Tassone; Maria Teresa Di Martino; Monica Ventura; Antonella Pietragalla; Iole Cucinotto; Teresa Calimeri; Alessandra Bulotta; Paola Neri; Michele Caraglia; Pierosandro Tagliaferri
Journal:  Cancer Biol Ther       Date:  2009-04-28       Impact factor: 4.742

10.  Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Authors:  S A Gayther; W Warren; S Mazoyer; P A Russell; P A Harrington; M Chiano; S Seal; R Hamoudi; E J van Rensburg; A M Dunning; R Love; G Evans; D Easton; D Clayton; M R Stratton; B A Ponder
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.